Metro Inc. (MRU)

Edition

Peralta independent valuation · 2026-11-18

12-month target · 2027-11-18

C$99.18

Intrinsic value today

C$94.27

Modeled total return

3.1%

Reference price C$97.58 on 2026-11-18. Total return includes modeled dividends and transaction costs. The target is a valuation checkpoint, not an automatic sale date.

Wait before adding Metro at C$97.58. Our independent 12-month target is C$99.18, offering 3.1% modeled total return. Food recovery and pharmacy growth support earnings, but rent and continued store investment limit cash conversion. A better entry price or stronger recovery and investment returns would improve the case.

Current Price

CAD 97.58

Street Consensus

CAD 101.36

Company details

Sector

Consumer Defensive

Industry

Grocery Stores

Market Capitalization

$20.6B

Primary Exchange

Toronto

Benchmark

XIC - Canada

Status

Watch

Current Price

CAD 97.58

Street Consensus

CAD 101.36

Sector

Consumer Defensive

Industry

Grocery Stores

Market Capitalization

$20.6B

Primary Exchange

Toronto

Benchmark

XIC - Canada

Status

Watch

Wait before adding Metro at C$97.58. Our independent 12-month target is C$99.18, offering 3.1% modeled total return. Food recovery and pharmacy growth support earnings, but rent and continued store investment limit cash conversion. A better entry price or stronger recovery and investment returns would improve the case.

Current Price

CAD 97.58

Street Consensus

CAD 101.36

Sector

Consumer Defensive

Industry

Grocery Stores

Market Capitalization

$20.6B

Primary Exchange

Toronto

Benchmark

XIC - Canada

Status

Watch

Key Catalysts

The next reported quarterly results can test whether food customers return after the strike and pharmacy growth persists. Conversion-program delivery should make recurring savings visible, while capital spending and lease-adjusted cash conversion show whether earnings recovery reaches shareholders. The dated model checkpoints are analyst review windows, not promised issuer publication dates.

Earnings Outlook

First-year base free cash flow before funded-debt interest is C$886.96 million, versus C$1,027.20 million in the fifth year. The forecast includes net lease cash, normalized taxes, maintenance and growth capital, working capital and a minority cash allowance. Recovery is a level improvement in earnings, while food and pharmacy growth and continued investment determine the longer-term path.

Investment Thesis

Metro combines recurring grocery demand with a growing pharmacy business, but a durable franchise is not automatically an attractive purchase at any price. At C$97.58, our 12-month target of C$99.18 offers only 3.1% modeled total return. We would wait for a better entry or evidence that recovery and investment productivity exceed our base.

Valuation Summary

Our independent 12-month target is C$99.18, against current intrinsic value of C$94.27 and a C$97.58 reference quote. Bear and bull targets are C$50.57 and C$188.93 without assigned probabilities. Base total return is 3.1% over the target horizon and 5.7% annualized over five years, including dividends and illustrative costs.

Wait before adding at the reference price. The central return is modest, while a large share of value depends on continuing-business assumptions beyond the explicit forecast. Reassess after food traffic recovery, cash conversion and store-conversion execution improve or the entry price falls. Existing-position sizing belongs to the portfolio decision; this report does not issue a trade.

Recent Developments

The latest full-year results show resilient pharmacy sales alongside grocery disruption from the Laval strike. Normal service resumed, but early subsequent food comparable sales remained negative. Store conversions and planned closures aim to improve the cost base. Management’s lost-profit estimate supports a recovery scenario; it is not cash owed back to the company.

Primary Risks To Thesis

The cautious stance could miss faster food recovery, sustained pharmacy growth or investment returns above our estimates. Continued traffic losses, discount competition, wage and supplier inflation or a higher required return would weaken value. Terminal assumptions, tax deductions, maintenance capital and share-award dilution are estimated; target precision should not be confused with forecast certainty.

Market Mispricing Rationale

Relative Performance

Historical return vs XIC · 2025-06-01–2026-06-01

The central disagreement is cash conversion rather than whether strike earnings can recover. Store investment, rent and interest consume cash that an adjusted-EPS multiple can obscure. Our base values gradual recovery but charges ongoing reinvestment. The strongest countercase is faster traffic recovery and more productive discount-store expansion, which would lift cash generation beyond this central forecast.